

Navigating the mental health impact of GLP-1s, with Rachel Goldman, PhD
Over the past several years, the rise of GLP-1 drugs such as Ozempic and Wegovy has changed the conversation around weight and obesity in the U.S. Rachel Goldman, PhD, talks about how GLP-1s work; the effects they can have on mental health; what questions to ask if you’re considering trying these medications; how…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Speaking of Psychology
See all episodes →
AI “de-skilling”: What happens when we offload our work to AI? With Brooke Macnamara, PhD

Why people cheat—and can relationships recover, with Galena Rhoades, PhD

Why does music move us? With Robert Zatorre, PhD
Similar episodes from other shows
More like Speaking of Psychology →
GLP-1s & eating disorders: a complicated relationship

Thoughts on Ozempic from a body-positive doctor

The Scale is LYING to You (& Destroying Your Self-Worth) with Dr. Rachel Goldman

Ozempic has Destabilized the Moral Value of Thinness - What Replaces it is Dystopian AF
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.